Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mario Togni

Showing results (101-110 of 122) with videos related to

Pageof 13
Sort By:
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|July 22, 2015
Long-term clinical outcomes of biodegradable polymer biolimus-eluting stents versus durable polymer everolimus-eluting stents in patients with coronary artery disease: three-year follow-up of the COMPARE II (Abluminal biodegradable polymer biolimus-eluting stent versus durable polymer everolimus-eluting stent) trialGeorgios J Vlachojannis, Pieter C Smits, Sjoerd H Hofma, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|October 2, 2010
Impact of arterial injury on neointimal hyperplasia after implantation of drug-eluting stents in coronary arteries: an intravascular ultrasound studyParham Eshtehardi, Stéphane Cook, Simon Wandel, et al.
Lancet (London, England)|February 5, 2013
Abluminal biodegradable polymer biolimus-eluting stent versus durable polymer everolimus-eluting stent (COMPARE II): a randomised, controlled, non-inferiority trialPieter Cornelis Smits, Sjoerd Hofma, Mario Togni, et al.
Circulation|August 8, 2007
Beneficial effect of recruitable collaterals: a 10-year follow-up study in patients with stable coronary artery disease undergoing quantitative collateral measurementsPascal Meier, Steffen Gloekler, Rainer Zbinden, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|August 30, 2025
Disparities in ST-elevation myocardial infarction diagnosis and management among patients with mental health conditionsDorian Garin, Erik Mendola, Yannick Faucherre, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|May 28, 2010
Sirolimus versus paclitaxel coronary stents in clinical practiceNiklas Millauer, Peter Jüni, Alexandra Hofmann, et al.
Circulation|July 22, 2009
Correlation of intravascular ultrasound findings with histopathological analysis of thrombus aspirates in patients with very late drug-eluting stent thrombosisStéphane Cook, Elena Ladich, Gaku Nakazawa, et al.
European Heart Journal|February 15, 2008
Two-year clinical outcome after implantation of sirolimus-eluting and paclitaxel-eluting stents in diabetic patientsMichael Billinger, Jonas Beutler, Keywan R Taghetchian, et al.
Circulation|June 8, 2011
Five-year clinical and angiographic outcomes of a randomized comparison of sirolimus-eluting and paclitaxel-eluting stents: results of the Sirolimus-Eluting Versus Paclitaxel-Eluting Stents for Coronary Revascularization LATE trialLorenz Räber, Lea Wohlwend, Mathias Wigger, et al.
JACC. Cardiovascular Interventions|June 25, 2011
Comparison of titanium-nitride-oxide-coated stents with zotarolimus-eluting stents for coronary revascularization a randomized controlled trialThomas Pilgrim, Lorenz Räber, Andreas Limacher, et al.
Pageof 13

Showing results (101-110 of 122) with videos related to

Sort By:
Pageof 13
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|July 22, 2015
Long-term clinical outcomes of biodegradable polymer biolimus-eluting stents versus durable polymer everolimus-eluting stents in patients with coronary artery disease: three-year follow-up of the COMPARE II (Abluminal biodegradable polymer biolimus-eluting stent versus durable polymer everolimus-eluting stent) trialGeorgios J Vlachojannis, Pieter C Smits, Sjoerd H Hofma, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|October 2, 2010
Impact of arterial injury on neointimal hyperplasia after implantation of drug-eluting stents in coronary arteries: an intravascular ultrasound studyParham Eshtehardi, Stéphane Cook, Simon Wandel, et al.
Lancet (London, England)|February 5, 2013
Abluminal biodegradable polymer biolimus-eluting stent versus durable polymer everolimus-eluting stent (COMPARE II): a randomised, controlled, non-inferiority trialPieter Cornelis Smits, Sjoerd Hofma, Mario Togni, et al.
Circulation|August 8, 2007
Beneficial effect of recruitable collaterals: a 10-year follow-up study in patients with stable coronary artery disease undergoing quantitative collateral measurementsPascal Meier, Steffen Gloekler, Rainer Zbinden, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|August 30, 2025
Disparities in ST-elevation myocardial infarction diagnosis and management among patients with mental health conditionsDorian Garin, Erik Mendola, Yannick Faucherre, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|May 28, 2010
Sirolimus versus paclitaxel coronary stents in clinical practiceNiklas Millauer, Peter Jüni, Alexandra Hofmann, et al.
Circulation|July 22, 2009
Correlation of intravascular ultrasound findings with histopathological analysis of thrombus aspirates in patients with very late drug-eluting stent thrombosisStéphane Cook, Elena Ladich, Gaku Nakazawa, et al.
European Heart Journal|February 15, 2008
Two-year clinical outcome after implantation of sirolimus-eluting and paclitaxel-eluting stents in diabetic patientsMichael Billinger, Jonas Beutler, Keywan R Taghetchian, et al.
Circulation|June 8, 2011
Five-year clinical and angiographic outcomes of a randomized comparison of sirolimus-eluting and paclitaxel-eluting stents: results of the Sirolimus-Eluting Versus Paclitaxel-Eluting Stents for Coronary Revascularization LATE trialLorenz Räber, Lea Wohlwend, Mathias Wigger, et al.
JACC. Cardiovascular Interventions|June 25, 2011
Comparison of titanium-nitride-oxide-coated stents with zotarolimus-eluting stents for coronary revascularization a randomized controlled trialThomas Pilgrim, Lorenz Räber, Andreas Limacher, et al.
Pageof 13